Lost $80 Million. Generated Cash. Both Are True

Rocket Lab just posted the best quarter in its history.

Revenue hit $268 million. That's up 73% from a year ago and $10 million above Wall Street's forecast.

The backlog surged 52% in a single quarter… to $3.57 billion.

And for the first time ever, Rocket Lab generated positive GAAP cash from operations.

$7.2 million.

So what did the stock do?

It fell 7% after hours.

Let me explain…

The headline said "miss." Rocket Lab lost $0.12 per share versus the $0.07 Wall Street expected.

That five-cent gap spooked traders.

But here's what the headline left out.

Buried in the income statement is a $27.3 million one-time charge. Rocket Lab terminated a bridge loan commitment related to its Iridium buy.

That's not an engine problem. It's a cleanup cost.

Strip it out, and the loss drops to about $0.08. One penny from the estimate.

In other words, the "miss" was a paperwork charge… not a crack in the business.

And the business is humming.

Rocket Lab signed $560 million in Neutron launch deals during Q3. Eight missions. Five customers.

The base price climbed to $70 million per flight.

And the rocket hasn't even flown yet.

That tells you how tight the launch market is. Customers are locking in rides years ahead… at rising prices.

Meanwhile, Space Systems revenue rose 13% from Q2 to $215 million. Twelve spacecraft reached orbit over the past year. More than 55 more are in development and build.

Q4 guidance came in strong — revenue of $270 to $290 million, gross margins of 34% to 36%.

Both would be records.

Now, I know what you're thinking. "If the numbers are that good, why didn't the stock hold?"

Fair question.

The stock ran up 11% before earnings dropped. Traders bought the rumor. When the EPS line flashed red, they sold.

It happens.

The signal is the backlog.

$3.57 billion is more than thirteen quarters of revenue at today's run rate.

And it's growing faster than Rocket Lab can fill it.

Rocket Lab also fully funded the Iridium deal. The ATM offering is done. Iridium's lenders signed off.

When that closes, Rocket Lab adds 66 satellites, a global network, and recurring revenue.

The stock will sort itself out.

I've been ahead of the crowd on Elon Musk, every step of the way.

After the so-called experts said Tesla was going bankrupt, I doubled down.

And the stock is up 1,510% since.

I was one of the first to correctly predict the SpaceX IPO.

And I've visited Musk's facilities across the country.

So I'm uniquely qualified to give this live demonstration of Musk's new 70x AI agent.

Click here to watch for free.

Space Systems brought in $214.8 million, or 80% of the quarter, up 88% from a year ago. Launch services made $53.1 million. But launch gross profit fell to $18.7 million from $23.8 million a year earlier, even as launch revenue rose. That puts the launch gross margin near 35%, down from about 58%. Spacecraft are carrying the growth, while launch earns less on each dollar. Watch launch margins as Neutron gets closer.

Rocket Lab raised $3.9 billion through its at-the-market stock offering in the first nine months of the year. Cash stood at $4.4 billion on Sept. 30, up from $829 million at the start of the year. Shares outstanding rose to 639 million from 544 million. The weighted share count was 652 million, 23% higher than a year earlier. That is why a net loss of $79.7 million becomes 12 cents a share… Watch the count. Rocket Lab guides to 681 million weighted shares next quarter, counting preferred shares.

Rocket Lab moved Neutron's first launch into 2027 on Oct. 14. On the call, Peter Beck gave no month, and the company said it will give a firmer timeline after first-stage tank tests. Management also said nothing will permanently fix negative cash flow until Neutron is in production, and that adjusted EBITDA should turn positive within about six months of a successful first flight. So the 16 booked Neutron missions are waiting on one rocket… Watch the tank tests.

Watch for three things.

First, Neutron's first-stage tank tests. Rocket Lab says a firmer launch timeline comes after them. Until then, the only date is "no earlier than 2027."

Second, Q4. Rocket Lab guides to revenue of $270 million to $290 million and an adjusted EBITDA loss of $14 million to $20 million. It also expects free cash flow to stay negative at elevated levels. So the positive operating cash flow in Q3 does not mean cash has stopped going out. Non-GAAP free cash flow was still a $23.9 million use in Q3…

Third, Iridium. Shareholders approved the deal, lenders agreed to keep Iridium's credit facility, and the funding is done. Regulatory reviews are still ahead, and the close is expected around mid-2027.

Rocket Lab's stock fell after the report as investors weighed the wider loss and the Neutron date. A record backlog is a promise. The next few quarters show how fast it turns into shipped hardware and cash.

Let's keep this simple.

Picture your monthly budget. This month you also paid a $200 fee to cancel an old gym contract. Your spending looks worse. But that fee will not come back next month.

That is a one-time charge. Companies report results two ways. GAAP counts everything. Adjusted results leave out items the company calls unusual.

Rocket Lab's Q3 shows both. The GAAP loss was $0.12 a share. Take out the $27.3 million tied to ending a bridge loan commitment, and the loss is about $0.08.

Is that fee really one-time? It points to a clear event. Rocket Lab cancelled the bridge loan after it funded the Iridium deal another way. That fits the label.

But look at the rest of the bill. Rocket Lab also booked $21.3 million in Iridium deal costs in Q3, after about $10 million in the first half. Costs like those may keep showing up until the deal closes…

Here is a simple test. Does the charge have a clear event? And does it have a clear end date? The bridge fee had both. Deal costs have an event, but no end until the close.

Follow the costs that repeat. One-time is only one-time if it stops.